Related Experiment Videos
[Tobacco: an atherogenic, thrombogenic or spasmogenic factor?]
1Service de physiologie, explorations fonctionnelles, hôpital Henri-Mondor, Créteil.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|December 2, 1998
Summary
Smoking significantly increases the risk of heart attack and cardiovascular complications. Its harmful effects on blood vessels and oxygen transport are key contributors to smoking-related mortality.
Area of Science:
- Cardiovascular Science
- Toxicology
- Public Health
Context:
- Smoking is a leading cause of preventable death globally.
- Myocardial infarction is the primary cause of mortality linked to smoking.
- Tobacco use accelerates atherosclerosis and triggers acute, potentially fatal, cardiovascular events.
Purpose:
- To elucidate the multifaceted mechanisms by which smoking contributes to cardiovascular morbidity and mortality.
- To identify the specific components and actions of cigarette smoke responsible for cardiac complications.
Summary:
- Smoking induces hypercoagulability, increases cardiac workload, reduces oxygen delivery, and causes coronary vasoconstriction.
- Nicotine and carbon monoxide are key mediators of these acute cardiovascular effects.
- Smoking's atherogenicity stems from adverse impacts on endothelial function, vascular tone, hemostasis, lipid profiles, and inflammatory responses.
- Oxidizing and toxic glycation products in smoke are principal mediators of vascular damage.
Impact:
- Highlights the critical need for smoking cessation to mitigate cardiovascular disease burden.
- Provides a basis for targeted interventions to counteract the detrimental vascular effects of smoking.
- Underscores the complex pathophysiology linking tobacco use to severe cardiovascular outcomes.